Literature DB >> 10507731

Loss of the SHOX gene associated with Leri-Weill dyschondrosteosis in a 45,X male.

L Stuppia1, G Calabrese, P Borrelli, V Gatta, E Morizio, R Mingarelli, M C Di Gilio, A Crinò, A Giannotti, G A Rappold, G Palka.   

Abstract

A male patient is reported with a 45,X karyotype and Leri-Weill dyschondrosteosis (LWD). FISH analysis with SHOX and SRY gene probes was carried out. One copy of both SHOX and SRY was detected in interphase nuclei, clarifying the origin of LWD and the male phenotype. Molecular results suggested that the 45,X karyotype arose through two independent events. The first occurred at paternal meiosis leading to an unequal crossing over between the short arms of the X and Y chromosomes. As a consequence, the SRY gene was translocated onto Xp, thereby explaining the male phenotype of the patient. The second event probably occurred at maternal meiosis or at the early stages of the zygote resulting in the loss of the maternal X chromosome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507731      PMCID: PMC1734422     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  3 in total

Review 1.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

2.  An infertile 45,X male with a SRY-bearing chromosome 13: a clinical case report and literature review.

Authors:  Di Peng; Yong-Sheng Zhang; Xin-Yue Zhang; Cong Hu; Mei-Han Liu; Rui-Zhi Liu
Journal:  J Assist Reprod Genet       Date:  2014-11-06       Impact factor: 3.412

3.  Spectrum of phenotypic anomalies in four families with deletion of the SHOX enhancer region.

Authors:  Valentina Gatta; Chiara Palka; Valentina Chiavaroli; Sara Franchi; Giovanni Cannataro; Massimo Savastano; Antonio Raffaele Cotroneo; Francesco Chiarelli; Angelika Mohn; Liborio Stuppia
Journal:  BMC Med Genet       Date:  2014-07-23       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.